NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/27/2023
Back to search
Official data from USPTO
THE PHARMACY FORMULA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
THE PHARMACY FORMULA
ST13
US500000097168596Class
30
Filing
97168596
Registration
7095225
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
06/27/2023
Trademark type
Word
Nice classes
30
Filing date
12/13/2021
Registration date
06/27/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/27/2023
Last transaction
06/27/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
06/01/2022
First use in commerce
06/01/2022
Drawing code
4
Owner type
01
Owner location
Richmond Hill, NY, US
Examiner
HSU, FONG
Law office
O20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
A. S. (pessoa física)
Representatives
Adam B. Portnow LAW OFFICE OF ADAM B. PORTNOW, P.L.
Technical classification
Nice Classes
Class 30
Vienna Codes
No Vienna codes available.
Goods and services
Class 30
Coffee; Coffee drinks
Publications
History of USPTO decisions and trademark events.
26 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
06/27/2023
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/22/2023
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
05/16/2023
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
05/15/2023
IUAA
USE AMENDMENT ACCEPTED
05/15/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/15/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
05/15/2023
ALIE
ASSIGNED TO LIE
05/15/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/08/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
05/08/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/08/2023
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
04/13/2023
IUAF
USE AMENDMENT FILED
04/13/2023
EAAU
TEAS AMENDMENT OF USE RECEIVED
04/12/2023
NREV
NOTICE OF REVIVAL - E-MAILED
04/11/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/10/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/10/2023
PETG
PETITION TO REVIVE-GRANTED
04/10/2023
PROA
TEAS PETITION TO REVIVE RECEIVED
04/10/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/23/2022
GNRT
NON-FINAL ACTION E-MAILED
09/23/2022
CNRT
NON-FINAL ACTION WRITTEN
09/23/2022
DOCK
ASSIGNED TO EXAMINER
09/20/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/16/2021
NWAP
NEW APPLICATION ENTERED
12/16/2021
Continuous trademark protection
Get notified about every new filing that threatens THE PHARMACY FORMULA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.